The average one-year price target for Assembly Biosciences (NasdaqGS:ASMB) has been revised to $48.70 / share. This is an increase of 24.84% from the prior estimate of $39.02 dated December 3, 2025.

The latest price target for Assembly Biosciences (NASDAQ:ASMB) was reported by Guggenheim on March 25, 2025. The analyst firm set a price target for $31.00 expecting ASMB to rise to within 12 months ...

SAN FRANCISCO — Ambitious California climate change legislation cleared a significant hurdle in the state Assembly yesterday, but advocates warn more challenges lie ahead. SAN FRANCISCO — Ambitious ...

Investing.com - Guggenheim raised its price target on Assembly Biosciences (NASDAQ:ASMB) to $39.00 from $31.00 on Monday, while maintaining a Buy rating on the stock. The company, currently trading at ...

Guggenheim raised the firm’s price target on Assembly Biosciences (ASMB) to $39 from $31 and keeps a Buy rating on the shares. Following interim data from Assembly’s Phase 1b study released last month ...

The average one-year price target for Assembly Biosciences (NASDAQ:ASMB) has been revised to 3.06 / share. This is an increase of 20.00% from the prior estimate of 2.55 dated August 1, 2023. The price ...

LAS VEGAS (FOX5) — A new strategy memo from the Democratic Party shows a focused effort to pick up seats in the Nevada Assembly during next year’s midterms. This week, the Nevada Assembly was added to ...